Periodic Reporting for period 1 - GD TCR LIGAND (Identification of the ligand of a human public anti-HCMV/cancer γδ T cell receptor)

γδ T cells, an important compartment of adaptive immune responses against infections and malignant transformation, have been proposed as a promising target for cancer immunotherapy. However, progress in this field is blocked by limited knowledge regarding the ligands of γδ...